CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy
Xue Bai(Northwest University), Zhong‐Yi Dong(Southern Medical University)
Cited by 58
Related Papers
Ginsenoside Rh4 inhibits colorectal cancer via the modulation of gut microbiota-mediated bile acid metabolism
|Journal of Advanced Research|2024|59
PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
|Cancer Research|2022|33